http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004116469-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47535fe04804c5e73983c0e734e86ed2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-52 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-52 |
filingDate | 2003-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc8950b0eeb8fa142793268fbd7229e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94013a321d9d9410c41168430dc18055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f9ba3a22e004556f24d1ee08555fc3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a6088cc210457fa7ded1b9182740ec |
publicationDate | 2004-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2004116469-A1 |
titleOfInvention | Quinoline-4-carboxamide derivatives as NK-2 and NK-3 receptor antagonists |
abstract | A compound, or a solvate or a salt thereof, of formula (I): wherein, Ar is an optionally substituted aryl or a C 5-7 cycloalkdienyl group, or a C 5-7 cycloalkyl group or an optionally substituted single or fused ring aromatic heterocyclic group; R is C 1-6 alkyl, C 3-7 cycloalkyl, C 3-7 cycloalkylalkyl, optionally substituted phenyl or phenyl C 1-6 alkyl, an optionally substituted five-membered heteroaromatic ring comprising up to four heteroatoms selected from O and N, hydroxy C 1-6 alkyl, amino C 1-6 alkyl, C 1-6 alkylaminoalkyl, di C 1-6 alkylaminoalkyl, C 1-6 acylaminoalkyl, C 1-6 alkoxyalkyl, C 1-6 alkylcarbonyl, carboxy, C 1-6 alkoxycarbonyl, C 1-6 alkoxycarbonyl C 1-6 alkyl, aminocarbonyl, C 1-6 alkylaminocarbonyl, di C 1-6 alkylaminocarbonyl, halogeno C 1-6 alkyl; or R is a group —(CH 2 ) p — wherein p is 2 or 3 which group forms a ring with a carbon atom of Ar, R 1 represents hydrogen or up to four optional substituents selected from the list consisting of: C 1-6 alkyl, C 1-6 alkenyl, aryl, C 1-6 alkoxy, hydroxy, halogen, nitro, cyano, carboxy, carboxamido, sulphonamido, C 1-6 alkoxycarbonyl, trifluoromethyl, acyloxy, phthalimido, amino or mono- and di-C 1-6 alkylamino; R 2 represents a moiety —(CH 2 ) n —NY 1 Y 2 wherein n is an integer in the range of from 1 to 9, Y 1 and Y 2 are independently selected from hydrogen; C 1-6 -alkyl; C 1-6 alkyl substituted with hydroxy, C 1-6 alkylamino or bis (C 1-6 alkyl) amino; C 1-6 -alkenyl; aryl or aryl-C 1-6 -alkyl or Y 1 and Y 2 together with the nitrogen atom to which they are attached represent an optionally substituted N-linked single or fused ring heterocyclic group; R 3 is branched or linear C 1-6 alkyl, C 3-7 cycloalkyl, C 4-7 cycloalkylalkyl, optionally substituted aryl, or an optionally substituted single of fuse ring aromatic heterocyclic group; and R 4 represents hydrogen or C 1-6 alkyl; a pharmaceutical composition comprising such a compound, process for preparing such a compound and the use of such a compound in medicine. |
priorityDate | 1997-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 525.